Published in Med J Aust on February 16, 1987
Postgraduate training of the medical staff of Australian teaching hospitals. Med J Aust (1994) 3.02
Gas-liquid chromatographic determination of theophylline in human plasma. J Chromatogr (1975) 1.54
The liver in congestive heart failure: a review. Am J Med Sci (1973) 1.50
Achalasia of the oesophagus: treatments with pneumatic dilatation. J Gastroenterol Hepatol (1991) 1.40
Physicians and the pharmaceutical industry. Intern Med J (2006) 1.39
Hemobilia secondary to percutaneous liver biopsy. Arch Intern Med (1972) 1.16
Hepatic encephalopathy: current status. Gastroenterology (1974) 1.10
Limitations of the clonal agar assay for the assessment of primary human ovarian tumour biopsies. Br J Cancer (1982) 1.10
Nitric oxide synthesis in the CNS endothelium and macrophages differs in its sensitivity to inhibition by arginine analogues. Life Sci (1991) 1.05
Intrahepatic cholestasis due to therapy of rheumatoid arthritis. Gastroenterology (1973) 1.04
Clinical thiamine deficiency in Australia: the size of the problem and approaches to prevention. Med J Aust (1980) 1.03
MDL 72,974: a potent and selective enzyme-activated irreversible inhibitor of monoamine oxidase type B with potential for use in Parkinson's disease. J Neural Transm Park Dis Dement Sect (1989) 0.99
Activity of 5,7-dichlorokynurenic acid, a potent antagonist at the N-methyl-D-aspartate receptor-associated glycine binding site. Mol Pharmacol (1990) 0.98
Effects of cimetidine and ranitidine on hepatic drug metabolism. Clin Pharmacol Ther (1982) 0.93
Idiopathic acute fatty liver of pregnancy. Gut (1970) 0.92
Neomycin absorption in man. Studies of oral and enema administration and effect of intestinal ulceration. Ann Intern Med (1972) 0.91
Paracetamol self-poisoning: diagnosis, management, and outcome. Med J Aust (1982) 0.91
(S)-(-)-5-ethynyl-3-(1-methyl-2-pyrrolidinyl)pyridine maleate (SIB-1508Y): a novel anti-parkinsonian agent with selectivity for neuronal nicotinic acetylcholine receptors. J Med Chem (1996) 0.90
Thiamine transport across the rat intestine. II. Effect of ethanol. J Lab Clin Med (1975) 0.90
Characterization of cell selectivity of two novel inhibitors of nitric oxide synthesis. Eur J Pharmacol (1992) 0.90
Decreased oral warfarin clearance after ranitidine and cimetidine. Clin Pharmacol Ther (1984) 0.87
The diagnosis of reflux oesophagitis: an evaluation of five investigative procedures. Aust N Z J Surg (1978) 0.87
Incidence of antibiotic-related diarrhoea and pseudomembranous colitis: a prospective study of lincomycin, clindamycin and ampicillin. Med J Aust (1977) 0.86
MDL 72145, an enzyme-activated irreversible inhibitor with selectivity for monoamine oxidase type B. J Neurochem (1984) 0.84
Enzyme-activated irreversible inhibitors of monoamine oxidase: phenylallylamine structure-activity relationships. J Med Chem (1985) 0.84
Effect of experimental hepatic injury on the clearance of phenobarbital and paraldehyde. Gastroenterology (1973) 0.84
Aluminum associated bone disease: clinico-pathologic correlation. Am J Kidney Dis (1982) 0.84
Uncomplicated subsequent pregnancy after idiopathic fatty liver of pregnancy. Obstet Gynecol (1972) 0.83
The effect of sex on certain properties of the very low density lipoprotein secreted by the liver. Biochem Biophys Res Commun (1974) 0.83
Inhibition of monoamine oxidase selectively in brain monoamine nerves using the bioprecursor (E)-beta-fluoromethylene-m-tyrosine (MDL 72394), a substrate for aromatic L-amino acid decarboxylase. J Neurochem (1985) 0.83
A [14C]phenacetin breath test to measure hepatic function in man. Hepatology (1984) 0.83
The acute effect of alcohol on hepatic coenzyme A and acetyl CoA concentrations. Proc Soc Exp Biol Med (1971) 0.82
Bromsulphthalein metabolism in acute alcoholic liver disease. Gut (1968) 0.81
Fatty liver induced by tetracycline in the rat. Dose-response relationships and effect of sex. Gastroenterology (1975) 0.81
Haloallylamine inhibitors of MAO and SSAO and their therapeutic potential. J Neural Transm Suppl (1994) 0.80
Resin activation capture technology: libraries from stabilized acyl-pyridinium on solid support. Biotechnol Bioeng (2000) 0.80
Multiple muscle enzyme release with psychiatric illness. J Nerv Ment Dis (1990) 0.80
Jejunal uptake of thiamin hydrochloride in man: influence of alcoholism and alcohol. Am J Clin Nutr (1985) 0.80
Mitochondrial dysfunction in alcoholic patients as assessed by breath analysis. Hepatology (1993) 0.79
3-(2-carboxyindol-3-yl)propionic acid derivatives: antagonists of the strychnine-insensitive glycine receptor associated with the N-methyl-D-aspartate receptor complex. J Med Chem (1990) 0.79
3-(2-Carboxyindol-3-yl)propionic acid-based antagonists of the N-methyl-D-aspartic acid receptor associated glycine binding site. J Med Chem (1992) 0.79
The effects of age and chronic liver disease on the elimination of temazepam. Eur J Clin Pharmacol (1986) 0.79
4-[[2-(1-Methyl-2-pyrrolidinyl)ethyl]thio]phenol hydrochloride (SIB-1553A): a novel cognitive enhancer with selectivity for neuronal nicotinic acetylcholine receptors. J Med Chem (1999) 0.79
Thiamine status in alcoholism. Aust N Z J Med (1977) 0.79
Prevalence of hepatitis B in a general hospital: screening of patients and staff. Med J Aust (1979) 0.78
Inhibition of rat aorta semicarbazide-sensitive amine oxidase by 2-phenyl-3-haloallylamines and related compounds. Biochem Pharmacol (1987) 0.78
Potent indole- and quinoline-containing N-methyl-D-aspartate antagonists acting at the strychnine-insensitive glycine binding site. J Pharmacol Exp Ther (1992) 0.78
Design and early clinical evaluation of selective inhibitors of monoamine oxidase. Prog Neuropsychopharmacol Biol Psychiatry (1988) 0.77
Recombinant human receptors and functional assays in the discovery of altinicline (SIB-1508Y), a novel acetylcholine-gated ion channel (nAChR) agonist. Pharm Acta Helv (2000) 0.77
Treatment of reflux oesophagitis. A randomized, controlled evaluation of cimetidine. Med J Aust (1983) 0.77
Hepatic coma: present concepts of pathogenesis and therapy. Prog Liver Dis (1972) 0.77
(E)-2-(3,4-dimethoxyphenyl)-3-fluoroallylamine: a selective, enzyme-activated inhibitor of type B monoamine oxidase. J Med Chem (1984) 0.77
MDL 72,974A: a selective MAO-B inhibitor with potential for treatment of Parkinson's disease. J Neural Transm Suppl (1993) 0.77
Enzyme-activated antagonists of the strychnine-insensitive glycine/NMDA receptor. J Med Chem (1994) 0.77
Cimetidine impairs the elimination of chlormethiazole. Eur J Clin Pharmacol (1981) 0.77
Wegener's granulomatosis--use of cyclosporin-A: a case report. Aust N Z J Med (1990) 0.77
Elevated serum CK in long abstinent cocaine abusers. Am J Drug Alcohol Abuse (1993) 0.77
Pharmacological characterization of SIB-1765F: a novel cholinergic ion channel agonist. J Pharmacol Exp Ther (1997) 0.76
The rational design of suicide substrates of amine oxidases. Biochem Soc Trans (1986) 0.76
Impaired doctors. The modern approach of medical boards. Aust Fam Physician (1998) 0.76
The effect of ethanol administration on the disposition and elimination of chlormethiazole. Eur J Clin Pharmacol (1983) 0.76
Clues to depression in primary care practice. Postgrad Med (1996) 0.76
Differential effects of all-trans retinoic acid on the growth of human keratinocytes and mouth carcinoma epidermoid cultures. Involvement of GRIM-19 and complex I of the respiratory chain. Int J Immunopathol Pharmacol (2008) 0.76
Doctors who self-administer drugs of dependence. Med J Aust (1998) 0.75
Heartburn--lifting the veil of mythology. Med J Aust (1993) 0.75
Professional development and ethics for today's and tomorrow's doctors. Med J Aust (2001) 0.75
Electronic record linkage to create diabetes registers. Impressive results can be obtained without record linkage. BMJ (1998) 0.75
(Z)-2-(2,4-Dichlorophenoxy)methyl-3-fluoroallylamine (MDL 72638): a clorgyline analogue with surprising selectivity for monoamine oxidase type B. Biochem Pharmacol (1986) 0.75
Dermahesive: a new concept in surgical dressings. Med J Aust (1977) 0.75
Letter: Pressure in Sengstaken tubes. Lancet (1976) 0.75
Liver function tests. CRC Crit Rev Clin Lab Sci (1971) 0.75
Ranitidine does not affect chlormethiazole or indocyanine green disposition. Clin Pharmacol Ther (1983) 0.75
Viral hepatitis in general hospitals: guidelines for control and prevention. Med J Aust (1978) 0.75
Patient care model project: St Vincent's Hospital, Melbourne. Aust Health Rev (1994) 0.75
Depletion of estrogen receptor in human breast tumor cells by a novel substituted indole that does not bind to the hormone binding domain. J Steroid Biochem Mol Biol (1996) 0.75
Use of single doses and rapid sampling to detect interactions with cimetidine. Eur J Clin Pharmacol (1984) 0.75
The site visit: its role in postgraduate training, continuing education and peer review. Aust N Z J Med (1980) 0.75
Postpartum microangiopathic haemolysis complicating severe preeclampsia. Aust N Z J Obstet Gynaecol (1997) 0.75
Chromosome damage and sister chromatid exchanges in lymphocyte cultures from patients with two primary cancers. Cancer Genet Cytogenet (1985) 0.75
Electroejaculation of the paraplegic male followed by pregnancy. Med J Aust (1975) 0.75
Hepatic vein occlusion (Budd-Chiari syndrome): problems in diagnosis and management. Aust N Z J Med (1986) 0.75
Single dose tinidazole prophylaxis in hysterectomy. Aust N Z J Obstet Gynaecol (1985) 0.75
Letter: Pseudomembranous colitis. Med J Aust (1975) 0.75
Effect of tetracycline on the metabolism of [1-14C]oleate by the liver. Biochem Pharmacol (1979) 0.75
Nausea from taking both lithium and trihexyphenidyl. Am J Psychiatry (1988) 0.75
Acute viral hepatitis: diagnosis and management. Aust Fam Physician (1981) 0.75
Dietary therapy of gastrointestinal disorders. Aust Fam Physician (1978) 0.75
Standard B.S.P. test: importance of sampling site. Lancet (1971) 0.75
Lincomycin-clindamycin-associated psuedomembranous colitis. Med J Aust (1976) 0.75
Disposition of intravenous glycofurol: effect of hepatic cirrhosis. Clin Pharmacol Ther (1984) 0.75
Secondary haemorrhage from the ovarian blood vessels--a case report. Aust N Z J Obstet Gynaecol (1965) 0.75
Extraction procedures for some common drugs in clinical and forensic toxicology. J Forensic Sci (1976) 0.75
(R)-4-oxo-5-phosphononorvaline: a new competitive glutamate antagonist at the NMDA receptor complex. J Med Chem (1990) 0.75
The prevention of Korsakoff's psychosis. Med J Aust (1979) 0.75
Incompetence of the cervix. Aust N Z J Obstet Gynaecol (1978) 0.75
Conformationally restricted analogues of nicotine and anabasine. Bioorg Med Chem Lett (1998) 0.75
Cervical cerclage. Clin Obstet Gynaecol (1980) 0.75
Multisubstrate inhibition of 4-hydroxybenzoate 3-monooxygenase. J Med Chem (1994) 0.75
John Kenneth Gabriel. Med J Aust (1977) 0.75
A view of education in obstetrics and gynecology. Med J Aust (1969) 0.75